MedTrace Logo

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

NCT05617183 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 268

Last updated 2023-03-27

No results posted yet for this study

Summary

This is a phase 1 study to compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled syringe of CT-P47 in Healthy Subjects.

Conditions

  • Healthy Subjects

Interventions

BIOLOGICAL

CT-P47

CT-P47, 162 mg in 0.9 mL, a single subcutaneous (SC) injection via auto-injector (AI)

BIOLOGICAL

CT-P47

CT-P47, 162 mg in 0.9 mL, a single subcutaneous (SC) injection via pre-filled syringe (PFS)

Sponsors & Collaborators

Principal Investigators

  • KyungSang Yu · Seoul National University College of Medicine and Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2023-04-30
Completion
2023-09-30
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05617183 on ClinicalTrials.gov